Description
Description: ALDACTONE-A is a pharmaceutical product manufactured by Pfizer. It contains Spironolactone as its active substance and is primarily used in the management of various conditions, including hypertension, heart failure, edema, and certain hormonal imbalances. ALDACTONE-A is available in tablet form, with each tablet containing 25 mg of Spironolactone.
Active Substance: Spironolactone is a potassium-sparing diuretic and aldosterone antagonist. It works by blocking the effects of aldosterone, a hormone that regulates sodium and water balance in the body. By inhibiting aldosterone, Spironolactone promotes the excretion of sodium and water while conserving potassium, leading to diuresis and reduction of fluid retention. Spironolactone is used in the treatment of hypertension, heart failure, edema associated with cirrhosis or nephrotic syndrome, and primary hyperaldosteronism.
Manufacturer: ALDACTONE-A is manufactured by Pfizer, a leading pharmaceutical company known for its wide range of medications and commitment to quality and innovation in healthcare. Pfizer adheres to stringent manufacturing standards to ensure the safety, efficacy, and consistency of its products.
Strength and Formulation: Each pack of ALDACTONE-A contains tablets, with each tablet containing 25 mg of Spironolactone as the active ingredient. The tablets are formulated for oral administration, making them convenient for patients to take as directed by their healthcare provider.
Indications: ALDACTONE-A (Spironolactone) is indicated for the treatment of the following:
- Hypertension: ALDACTONE-A can be used alone or in combination with other antihypertensive agents for the management of hypertension.
- Heart failure: ALDACTONE-A is indicated for the treatment of heart failure, particularly in patients with reduced ejection fraction, to improve symptoms and reduce the risk of hospitalization.
- Edema: ALDACTONE-A is used to manage edema associated with various conditions, including cirrhosis of the liver, nephrotic syndrome, and heart failure.
- Primary hyperaldosteronism: ALDACTONE-A is indicated for the diagnosis and treatment of primary hyperaldosteronism, a condition characterized by excessive aldosterone production by the adrenal glands.
Usage and Dosage: The recommended dosage of ALDACTONE-A (Spironolactone) may vary depending on the patient’s medical condition, treatment response, and individual factors. It is usually taken orally once daily, with or without food. The dosage may be adjusted by the prescribing healthcare provider based on the patient’s response to treatment and serum potassium levels.
Storage Conditions: ALDACTONE-A tablets should be stored according to the manufacturer’s instructions, typically in a cool, dry place, away from direct sunlight, and at room temperature. They should be kept out of reach of children and pets to prevent accidental ingestion. Proper storage helps maintain the stability and efficacy of the medication.
Patients should consult their healthcare provider for personalized information regarding the use of ALDACTONE-A, including dosage adjustments, potential side effects, and monitoring during treatment. Regular follow-up appointments are essential to evaluate treatment response and manage any adverse reactions.
Reviews
There are no reviews yet.